James C. Cusack
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 16
- Colorectal Cancer Surgical Treatments 15
- Cancer-related Molecular Pathways 9
- Cancer Research top 1%
- NF-κB Signaling Pathways 8
- Molecular Biology top 2%
- Cell death mechanisms and regulation 9
- Ubiquitin and proteasome pathways 9
- Toxicology top 2%
- Biotechnology top 2%
-
- Colorectal and Anal Carcinomas 14
-
- Virus-based gene therapy research 6
- Co-authors
- Albert S. BaldwinRong LiuCun-Yu WangJulian AdamsPeter J. ElliottJack A. RothLaurie B. Owen‐SchaubMichael E. Houston
- Journals
- Annals of Surgical Oncology (8 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesUgandaUnited Kingdom
In The Last Decade
James C. Cusack
84 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 2.7k
- Cancer Research 1.3k
- Molecular Biology 2.6k
- Toxicology 108
- Biotechnology 271
Countries citing papers authored by James C. Cusack
This map shows the geographic impact of James C. Cusack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Cusack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Cusack more than expected).
Fields of papers citing papers by James C. Cusack
This network shows the impact of papers produced by James C. Cusack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Cusack. The network helps show where James C. Cusack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James C. Cusack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 13 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 0 | |
| 7 | 2019 | 22 | |
| 8 | 2017 | 39 | |
| 9 | 2015 | 36 | |
| 10 | 2014 | 49 | |
| 11 | 2013 | 57 | |
| 12 | 2013 | 34 | |
| 13 | 2012 | 87 | |
| 14 | 2012 | 77 | |
| 15 | Oral proteasome inhibitor (NPI-0052) enhances sensitivity to combination Gemcitabine and Erbitux in a pancreatic cancer xenograft model | 2005 | 1 |
| 16 | 2003 | 83 | |
| 17 | 2002 | 17 | |
| 18 | High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus. | 1996 | 27 |
| 19 | Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expressionbreakdown → | 1995 | 615 |
| 20 | 1994 | 32 |
About James C. Cusack
James C. Cusack is a scholar working on Oncology, Cancer Research, Hepatology, Health Informatics and Surgery, having authored 89 papers that have together received 5.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Colorectal Cancer Surgical Treatments (15 papers), Colorectal and Anal Carcinomas (14 papers), Cell death mechanisms and regulation (9 papers), Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (9 papers), NF-κB Signaling Pathways (8 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (1.3k citations), Molecular Biology (2.6k citations), Toxicology (108 citations) and Biotechnology (271 citations). James C. Cusack has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include Albert S. Baldwin, Rong Liu, Cun-Yu Wang, Julian Adams, Peter J. Elliott, Jack A. Roth, Laurie B. Owen‐Schaub, Michael E. Houston, Derek J. Erstad and Sybil M. Santee. Their work appears in journals such as Annals of Surgical Oncology, Journal of Clinical Oncology, Clinical Cancer Research, The American Journal of Surgery and Surgical Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.